Medicare Enrolled
Dr. David Rahimian, D.O.
Vascular Neurology Physician · New Hyde Park, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rahimian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rahimian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rahimian
Dr. David Rahimian is a vascular neurology physician in New Hyde Park, NY, with 11 years of NPI registration. Based on federal Medicare data, Dr. Rahimian performed 3,077 Medicare services across 1,955 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rahimian received a total of $11,687 from 60 pharmaceutical and/or device companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in vascular neurology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rahimian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 2% volume in NY
$11,687 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,077
Medicare services
Top 2% in NY for vascular neurology physician
1,955
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~280 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,059 | $72 | $91 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
567 | $118 | $154 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
420 | $153 | $206 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
327 | $108 | $138 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
284 | $74 | $94 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
173 | $195 | $245 |
| Emergency department visit, high complexity An emergency department visit involving a high level of medical decision making. |
95 | $158 | $203 |
| New patient office visit, complex (60-74 min) | 86 | $192 | $257 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
24 | $33 | $41 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
21 | $116 | $144 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
21 | $34 | $42 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,687
Total received (2021-2024)
Avg $2,922/year across 4 years
Top 20% in NY for vascular neurology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
500
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,687 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,556
2023
$3,066
2022
$2,165
2021
$1,900
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$686
Alexion Pharmaceuticals, Inc.
$495
TG Therapeutics, Inc.
$396
PFIZER INC.
$362
SK Life Science, Inc.
$304
Lundbeck LLC
$256
AstraZeneca Pharmaceuticals LP
$165
ARGENX US, INC.
$158
Eisai Inc.
$154
Takeda Pharmaceuticals U.S.A., Inc.
$126
Amylyx Pharmaceuticals, Inc.
$125
DePuy Synthes Sales Inc.
$125
Alnylam Pharmaceuticals Inc.
$125
Neurocrine Biosciences, Inc.
$106
Amgen Inc.
$100
Genentech USA, Inc.
$89
Biogen, Inc.
$86
Otsuka America Pharmaceutical, Inc.
$72
SCILEX PHARMACEUTICALS INC.
$68
Chiesi USA, Inc.
$68
Merck Sharp & Dohme LLC
$61
Grifols USA, LLC
$50
Kyowa Kirin, Inc.
$49
Acorda Therapeutics, Inc
$44
Lilly USA, LLC
$41
Cumberland Pharmaceuticals, Inc.
$36
MDD US Operations, LLC
$35
Ipsen Biopharmaceuticals, Inc
$33
Boston Scientific Corporation
$28
EAGLE PHARMACEUTICALS, INC.
$27
CSL Behring
$21
Azurity Pharmaceuticals, Inc.
$20
Vanda Pharmaceuticals Inc.
$16
Novartis Pharmaceuticals Corporation
$15
ACADIA Pharmaceuticals Inc
$14
Top 3 companies account for 34.6% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,682
Alexion Pharmaceuticals, Inc.
$877
AbbVie Inc.
$747
Neurocrine Biosciences, Inc.
$731
SK Life Science, Inc.
$730
PFIZER INC.
$717
Lundbeck LLC
$708
TG Therapeutics, Inc.
$396
Takeda Pharmaceuticals U.S.A., Inc.
$315
ARGENX US, INC.
$291
Biogen, Inc.
$286
Chiesi USA, Inc.
$260
Horizon Therapeutics plc
$218
IMPEL PHARMACEUTICALS INC.
$214
AstraZeneca Pharmaceuticals LP
$211
EMD Serono, Inc.
$208
Cumberland Pharmaceuticals, Inc.
$200
Merck Sharp & Dohme LLC
$178
Grifols USA, LLC
$175
Eisai Inc.
$169
Amgen Inc.
$156
Lilly USA, LLC
$144
Alnylam Pharmaceuticals Inc.
$142
Penumbra, Inc.
$140
Mallinckrodt Hospital Products Inc.
$131
Amylyx Pharmaceuticals, Inc.
$125
DePuy Synthes Sales Inc.
$125
Kyowa Kirin, Inc.
$105
Biohaven Pharmaceutical Holding Company Ltd.
$96
Teva Pharmaceuticals USA, Inc.
$93
Corium, LLC
$93
Genentech USA, Inc.
$89
ACADIA Pharmaceuticals Inc
$87
Otsuka America Pharmaceutical, Inc.
$72
SCILEX PHARMACEUTICALS INC.
$68
Novartis Pharmaceuticals Corporation
$52
CATALYST PHARMACEUTICALS, INC.
$50
Avanir Pharmaceuticals, Inc.
$48
Acorda Therapeutics, Inc
$44
MITSUBISHI TANABE PHARMA AMERICA, INC.
$42
BANNER LIFE SCIENCES, LLC
$39
MDD US Operations, LLC
$35
Janssen Pharmaceuticals, Inc
$33
Ipsen Biopharmaceuticals, Inc
$33
Octapharma USA, Inc.
$30
Boston Scientific Corporation
$28
EAGLE PHARMACEUTICALS, INC.
$27
Xeris Pharmaceuticals, Inc.
$25
Merz Pharmaceuticals, LLC
$24
Supernus Pharmaceuticals, Inc.
$23
GENZYME CORPORATION
$22
CSL Behring
$21
Azurity Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme Corporation
$19
Neurelis, Inc.
$17
Celgene Corporation
$17
Mylan Specialty L.P.
$16
Vanda Pharmaceuticals Inc.
$16
EISAI INC.
$16
GE HealthCare
$13
Top 3 companies account for 28.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · BAFIERTAM · BARHEMSYS · BOTOX · BRIDION · BRILINTA · BRIUMVI · CALDOLOR · CLEVIPREX · Dysport · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · FIRDAPSE · GAMMAGARD · GAMMAGARD LIQUID · Gamunex-C · Glatiramer Acetate · Gocovri · HYQVIA · Hizentra · INBRIJA · INGREZZA · KENGREAL · KESIMPTA · KEVEYIS · KISUNLA · LEQEMBI · LUX-Dx Insertable Cardiac Monitor · Leqembi · MAVENCLAD · Mavenclad · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PONVORY · Penumbra System · QULIPTA · RADICAVA · RELYVRIO · REXULTI · SOLIRIS · Soliris · TYSABRI · Teligen · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · XCOPRI · Xeomin · ZEPOSIA · ZONISADE · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Vascular neurology physicians within 10 mi
49
Per 100K population
3.5
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rahimian is a clinical cardiology specialist, with above-average Medicare volume (top 2% in NY), with low-engagement industry engagement in the top 20% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rahimian experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Rahimian performed 1,059 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rahimian receive payments from pharmaceutical companies?
Yes. Dr. Rahimian received a total of $11,687 from 60 companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rahimian's costs compare to other vascular neurology physicians in New Hyde Park?
Dr. Rahimian's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rahimian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Vascular Neurology Physicians in New Hyde Park
Browse vascular neurology physicians in New Hyde Park ranked by procedure volume and transparency data.
Highest volume
Top Vascular Neurology Physicians in NY
Vascular neurology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Vascular Neurology Physicians in NY
Which NY vascular neurology physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology